- Issuer ticker
-
EW
- Reported as of
-
28 Jul 2026
- Net transaction value
-
-$818,958
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
28 Jul 2026, 19:40:47 UTC
Reporting owner
1 detail
- Reporting owner signature
-
Linda J. Park, Attorney-in-Fact
Key filing fact
Wayne Markowitz filed Form 4 for Edwards Lifesciences Corp (EW) on 28 Jul 2026.
Key facts
- This page summarizes Wayne Markowitz's Form 4 filing for Edwards Lifesciences Corp (EW).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Jul 2026, 19:40.
Change
- Previous filing in this sequence was filed on 11 May 2026.
- Current net transaction value: -$818,958.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001991414
Primary reporting owner
Markowitz Wayne
- Relationship
-
CVP, JAPAC
- Address
- ONE EDWARDS WAY, IRVINE
- Signature
- Linda J. Park, Attorney-in-Fact
- Signature date
- 28 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EW
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +9,628
- Change %
- +44%
- Price
-
$74.02*
- Shares after
- 31,308
- Date
- 28 Jul 2026
- Ownership
- Direct
EW
transaction
Common Stock
Sale
- Transaction value
- $818,958
- Shares
- -9,628
- Change %
- -31%
- Price
-
$85.06
- Shares after
- 21,680
- Date
- 28 Jul 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EW
transaction
Derivative
Employee Stock Option (Right to Acquire)
Options Exercise
- Transaction value
- Shares
- -9,628
- Change %
- -50%
- Price
-
$0.000000*
- Shares after
- 9,628
- Date
- 28 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,628
- Exercise price
- $74.02
* marks a reported price that did not pass the local price check.
SEC remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.